Beijing Cancer Hospital ( Site 2411)

Beijing, Beijing Municipality 100142

0 studies enrolling now · 1 studies all time

What they study most

NSCLC, Non-small Cell Lung Cancer

Studies at this site

• Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023] — Recruiting now